<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01295840</url>
  </required_header>
  <id_info>
    <org_study_id>CR 10-046-SP-HF</org_study_id>
    <nct_id>NCT01295840</nct_id>
  </id_info>
  <brief_title>Quartet Lead and Resynchronization Therapy Options</brief_title>
  <acronym>QUARTO</acronym>
  <official_title>QUARTET LEAD AND RESYNCHRONIZATION THERAPY OPTIONS To Investigate the Stimulatory Possibilities Offered by the Different Configurations Available for the Quartet Lead and Their Effect on Haemodynamic and Clinical Response.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Jude Medical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>St. Jude Medical</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this Clinical Trial is to determine the percentage of patients whose
      hemodynamic response improves with the different configurations offered by the new Quartet®
      left ventricular lead, as a result of its four electrodes, with respect to the configurations
      offered by a standard bipolar lead.

      Furthermore, the optimal stimulation configuration will be determined from a comparison with
      traditional configurations.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective, non-randomised, multi-centre, national, interventional clinical trial
      of a medical device.

      This trial involves two visits: one at the beginning of the study, which will be undertaken
      in the seven days following implant, and another visit at 6 months after enrollment. It is
      recommended that the enrollment visit is undertaken as soon as possible after implantation,
      although the time window allows the timing to be adapted to each centre's standard practice.
      Resynchronization therapy in those patients suitable for participation in this trial is
      expected to begin once this enrollment visit has been completed.

      Once data collection at enrollment visit has been completed, final device programming will be
      based on each investigator's criteria and will be undertaken following the standard practice
      of each centre.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2011</start_date>
  <completion_date type="Actual">September 2012</completion_date>
  <primary_completion_date type="Actual">April 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Patients Whose Cardiac Output (CO) Value in Acute, as Measured Echocardiographically, Improves With the Different Stimulation Vectors Offered by the Quartet® Left Ventricular Electrode.</measure>
    <time_frame>Enrollment visit (in the seven days after implantation of the device)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percent Difference Between the Best CO From Non-traditional Vectors and Best CO From Traditional Vectors</measure>
    <time_frame>At enrollment</time_frame>
    <description>In patients with best CO obtained from Non-traditional, to calculate the percent difference between the best CO from Non-traditional vectors and best CO from Traditional vectors, vectors.This percentage was the CO from Non-traditional vectors minus CO from Traditional vectors then divided by CO from Traditional vectors.
The Quartet® lead has 4 poles: Distal (D1), Mid 2 (M2), Mid 3 (M3) and Proximal (P4). The 3 Traditional vectors are the traditional configurations available in a standard bipolar lead: D1-M2, D1-Right Ventricular Coil (RVC) and M2-RVC. The 7 Non-traditional vectors are the additional configurations available in a Quartet® lead: D1-P4, M2-P4, M3-M2, M3-RVC, M3-P4, P4-M2 and P4-RVC.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiac Output (CO) With Different Configurations at Enrollment</measure>
    <time_frame>Enrollment visit (in the seven days after implantation of the device)</time_frame>
    <description>Means of baseline non-paced CO, best CO obtained from traditional configurations and best CO obtained from all quadripolar configurations at enrollment.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Capture Threshold</measure>
    <time_frame>Enrollment visit (in the seven days after implantation of the device)</time_frame>
    <description>Capture and phrenic threshold data will be recorded for each of the stimulation vectors studied.
Attempts will also be made to avoid phrenic stimulation in those patients who suffer from it, whilst maintaining good capture thresholds, by changing between the new configurations offered by the Quartet® electrode.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Capture Threshold</measure>
    <time_frame>6 months post-implant</time_frame>
    <description>Capture and phrenic threshold data will be recorded for each of the stimulation vectors studied.
Attempts will also be made to avoid phrenic stimulation in those patients who suffer from it, whilst maintaining good capture thresholds, by changing between the new configurations offered by the Quartet® electrode.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Vectors With Phrenic Nerve Stimulation (PNS)</measure>
    <time_frame>Enrollment visit (in the seven days after implantation of the device)</time_frame>
    <description>Capture and phrenic threshold data will be recorded for each of the stimulation vectors studied.
Attempts will also be made to avoid phrenic stimulation in those patients who suffer from it, while maintaining good capture thresholds, by changing between the new configurations offered by the Quartet® electrode.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Vectors With Phrenic Nerve Stimulation (PNS)</measure>
    <time_frame>At 6 months</time_frame>
    <description>Capture and phrenic threshold data will be recorded for each of the stimulation vectors studied.
Attempts will also be made to avoid phrenic stimulation in those patients who suffer from it, whilst maintaining good capture thresholds, by changing between the new configurations offered by the Quartet® electrode.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Patients With PNS in All Vectors</measure>
    <time_frame>At enrollment</time_frame>
    <description>To calculate the number of patients that exhibit PNS in all traditional vector</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Patients With PNS in All Vectors, That Could be Avoided With a Non-traditional Vector</measure>
    <time_frame>At enrollment</time_frame>
    <description>To calculate the number of patients, who exhibit PNS in all traditional vector, in which PNS could be avoided using a non-traditional vector</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Patients With PNS in All Vectors</measure>
    <time_frame>At 6 months</time_frame>
    <description>To calculate the number of patients that exhibit PNS in all traditional vector</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Patients With PNS in All Vectors, That Could be Avoided With a Non-traditional Vector</measure>
    <time_frame>At 6 months</time_frame>
    <description>To calculate the number of patients, who exhibit PNS in all traditional vector, in which PNS could be avoided using a non-traditional vector</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">51</enrollment>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>CRT therapy</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Cardiac Resynchronization Therapy Defibrillator (CRT-D)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cardiac Resynchronization Therapy Defibrillator</intervention_name>
    <description>Cardiac Resynchronization Therapy Defibrillator</description>
    <arm_group_label>CRT therapy</arm_group_label>
    <other_name>Promote Q. Model</other_name>
    <other_name>Promote Quadra™.</other_name>
    <other_name>Quartet®: Tetrapolar left ventricular lead. Model 1458Q.</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients with a Cardiac resynchronization Therapy Defibrillator device (CRT-D) and a
             Quartet® quadripolar electrode from St Jude Medical (used in &quot;Single Site Pacing&quot;
             mode) implanted in the left ventricle.

          2. Patients who have provided written informed consent

          3. Patients who are in sinus rhythm.

          4. Patients older than 18 years of age.

        Exclusion Criteria:

          1. Patients in atrial fibrillation at the time of the echocardiographic study of the
             enrollment visit.

          2. Patients with valvular disease.

          3. Patients in functional class New York Heart Association (NYHA) IV

          4. Patients for whom echocardiography images suitable for determining the cardiac output
             cannot be obtained.

          5. Patients whose device has been changed/upgraded.

          6. Pregnant patients.

          7. Patients who do not fulfill all the inclusion criteria.

          8. Patients who are unable to provide written informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dr. Francisco Javier Alzueta Rodríguez, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Clínico Universitario Virgen de la Victoria</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital Clínico Universitario Virgen de la Victoria</name>
      <address>
        <city>Málaga</city>
        <zip>29010</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>March 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 3, 2011</study_first_submitted>
  <study_first_submitted_qc>February 10, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 15, 2011</study_first_posted>
  <results_first_submitted>June 6, 2014</results_first_submitted>
  <results_first_submitted_qc>March 5, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">March 6, 2015</results_first_posted>
  <last_update_submitted>March 5, 2015</last_update_submitted>
  <last_update_submitted_qc>March 5, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 6, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ethinyl estradiol, levonorgestrel drug combination</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>The recruitment target is approximately 50 patients. Recruitment will be competitive, and will last for approximately 12 months, plus six months of follow-up. The trial will finish once all the patients have completed the follow-up.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>No Arms</title>
          <description>All patient have a Quartet Left Ventricular (LV) lead. No arms.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="51"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="50"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>No Arms</title>
          <description>All patient have a Quartet LV lead. No arms.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="51"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="65.4" spread="9.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Patients Whose Cardiac Output (CO) Value in Acute, as Measured Echocardiographically, Improves With the Different Stimulation Vectors Offered by the Quartet® Left Ventricular Electrode.</title>
        <time_frame>Enrollment visit (in the seven days after implantation of the device)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>No Arms</title>
            <description>All patient have a Quartet LV lead. No arms.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Patients Whose Cardiac Output (CO) Value in Acute, as Measured Echocardiographically, Improves With the Different Stimulation Vectors Offered by the Quartet® Left Ventricular Electrode.</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="51"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percent Difference Between the Best CO From Non-traditional Vectors and Best CO From Traditional Vectors</title>
        <description>In patients with best CO obtained from Non-traditional, to calculate the percent difference between the best CO from Non-traditional vectors and best CO from Traditional vectors, vectors.This percentage was the CO from Non-traditional vectors minus CO from Traditional vectors then divided by CO from Traditional vectors.
The Quartet® lead has 4 poles: Distal (D1), Mid 2 (M2), Mid 3 (M3) and Proximal (P4). The 3 Traditional vectors are the traditional configurations available in a standard bipolar lead: D1-M2, D1-Right Ventricular Coil (RVC) and M2-RVC. The 7 Non-traditional vectors are the additional configurations available in a Quartet® lead: D1-P4, M2-P4, M3-M2, M3-RVC, M3-P4, P4-M2 and P4-RVC.</description>
        <time_frame>At enrollment</time_frame>
        <group_list>
          <group group_id="O1">
            <title>No Arms</title>
            <description>All patient have a Quartet LV lead. No arms</description>
          </group>
        </group_list>
        <measure>
          <title>Percent Difference Between the Best CO From Non-traditional Vectors and Best CO From Traditional Vectors</title>
          <description>In patients with best CO obtained from Non-traditional, to calculate the percent difference between the best CO from Non-traditional vectors and best CO from Traditional vectors, vectors.This percentage was the CO from Non-traditional vectors minus CO from Traditional vectors then divided by CO from Traditional vectors.
The Quartet® lead has 4 poles: Distal (D1), Mid 2 (M2), Mid 3 (M3) and Proximal (P4). The 3 Traditional vectors are the traditional configurations available in a standard bipolar lead: D1-M2, D1-Right Ventricular Coil (RVC) and M2-RVC. The 7 Non-traditional vectors are the additional configurations available in a Quartet® lead: D1-P4, M2-P4, M3-M2, M3-RVC, M3-P4, P4-M2 and P4-RVC.</description>
          <units>percentage of difference of CO</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="51"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.69" spread="11.12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Cardiac Output (CO) With Different Configurations at Enrollment</title>
        <description>Means of baseline non-paced CO, best CO obtained from traditional configurations and best CO obtained from all quadripolar configurations at enrollment.</description>
        <time_frame>Enrollment visit (in the seven days after implantation of the device)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>No Arms</title>
            <description>All patient have a Quartet LV lead. No arms</description>
          </group>
        </group_list>
        <measure>
          <title>Cardiac Output (CO) With Different Configurations at Enrollment</title>
          <description>Means of baseline non-paced CO, best CO obtained from traditional configurations and best CO obtained from all quadripolar configurations at enrollment.</description>
          <units>L/min</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="51"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Non-paced CO</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.64" spread="0.94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Best CO with Traditional vectors</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.16" spread="1.12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Best CO with All vectors available in Quartet lead</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.33" spread="1.12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Capture Threshold</title>
        <description>Capture and phrenic threshold data will be recorded for each of the stimulation vectors studied.
Attempts will also be made to avoid phrenic stimulation in those patients who suffer from it, whilst maintaining good capture thresholds, by changing between the new configurations offered by the Quartet® electrode.</description>
        <time_frame>Enrollment visit (in the seven days after implantation of the device)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>No Arms</title>
            <description>All patient have a Quartet LV lead. No arms</description>
          </group>
        </group_list>
        <measure>
          <title>Capture Threshold</title>
          <description>Capture and phrenic threshold data will be recorded for each of the stimulation vectors studied.
Attempts will also be made to avoid phrenic stimulation in those patients who suffer from it, whilst maintaining good capture thresholds, by changing between the new configurations offered by the Quartet® electrode.</description>
          <units>volts</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="51"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Best Capture Threshold for Traditional vectors</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.79" spread="0.47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Best Capture Threshold for Non-Traditional vectors</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.97" spread="0.55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Best Capture Threshold for all vectors</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.72" spread="0.32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Capture Threshold</title>
        <description>Capture and phrenic threshold data will be recorded for each of the stimulation vectors studied.
Attempts will also be made to avoid phrenic stimulation in those patients who suffer from it, whilst maintaining good capture thresholds, by changing between the new configurations offered by the Quartet® electrode.</description>
        <time_frame>6 months post-implant</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Quartet LV Lead</title>
            <description>All patient have a Quartet LV lead. No arms</description>
          </group>
        </group_list>
        <measure>
          <title>Capture Threshold</title>
          <description>Capture and phrenic threshold data will be recorded for each of the stimulation vectors studied.
Attempts will also be made to avoid phrenic stimulation in those patients who suffer from it, whilst maintaining good capture thresholds, by changing between the new configurations offered by the Quartet® electrode.</description>
          <units>volts</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="50"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Best Capture Threshold for Traditional vectors</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.96" spread="0.54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Best Capture Threshold for Non-Traditional vectors</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.21" spread="0.47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Best Capture Threshold for all vectors</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.90" spread="0.41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Vectors With Phrenic Nerve Stimulation (PNS)</title>
        <description>Capture and phrenic threshold data will be recorded for each of the stimulation vectors studied.
Attempts will also be made to avoid phrenic stimulation in those patients who suffer from it, while maintaining good capture thresholds, by changing between the new configurations offered by the Quartet® electrode.</description>
        <time_frame>Enrollment visit (in the seven days after implantation of the device)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>No Arms</title>
            <description>All patient have a Quartet LV lead. No arms</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Vectors With Phrenic Nerve Stimulation (PNS)</title>
          <description>Capture and phrenic threshold data will be recorded for each of the stimulation vectors studied.
Attempts will also be made to avoid phrenic stimulation in those patients who suffer from it, while maintaining good capture thresholds, by changing between the new configurations offered by the Quartet® electrode.</description>
          <units>number of vectors</units>
          <param>Number</param>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="51"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Number of total vectors</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="510"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Number of Traditional vectors with PNS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Number of Non-Traditional vectors with PNS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Number of Total vectors with PNS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="120"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Vectors With Phrenic Nerve Stimulation (PNS)</title>
        <description>Capture and phrenic threshold data will be recorded for each of the stimulation vectors studied.
Attempts will also be made to avoid phrenic stimulation in those patients who suffer from it, whilst maintaining good capture thresholds, by changing between the new configurations offered by the Quartet® electrode.</description>
        <time_frame>At 6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>No Arms</title>
            <description>All patient have a Quartet LV lead. No arms</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Vectors With Phrenic Nerve Stimulation (PNS)</title>
          <description>Capture and phrenic threshold data will be recorded for each of the stimulation vectors studied.
Attempts will also be made to avoid phrenic stimulation in those patients who suffer from it, whilst maintaining good capture thresholds, by changing between the new configurations offered by the Quartet® electrode.</description>
          <units>number of vectors</units>
          <param>Number</param>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="50"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Number of vectors</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="510"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Number of Traditional vectors with PNS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Number of Non-Traditional vectors with PNS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Number of Total vectors with PNS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="118"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Patients With PNS in All Vectors</title>
        <description>To calculate the number of patients that exhibit PNS in all traditional vector</description>
        <time_frame>At enrollment</time_frame>
        <group_list>
          <group group_id="O1">
            <title>No Arms</title>
            <description>All patient have a Quartet LV lead. No arms</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Patients With PNS in All Vectors</title>
          <description>To calculate the number of patients that exhibit PNS in all traditional vector</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="51"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Patients With PNS in All Vectors, That Could be Avoided With a Non-traditional Vector</title>
        <description>To calculate the number of patients, who exhibit PNS in all traditional vector, in which PNS could be avoided using a non-traditional vector</description>
        <time_frame>At enrollment</time_frame>
        <group_list>
          <group group_id="O1">
            <title>No Arms</title>
            <description>All patient have a Quartet LV lead. No arms</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Patients With PNS in All Vectors, That Could be Avoided With a Non-traditional Vector</title>
          <description>To calculate the number of patients, who exhibit PNS in all traditional vector, in which PNS could be avoided using a non-traditional vector</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="51"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Patients With PNS in All Vectors</title>
        <description>To calculate the number of patients that exhibit PNS in all traditional vector</description>
        <time_frame>At 6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>No Arms</title>
            <description>All patient have a Quartet LV lead. No arms</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Patients With PNS in All Vectors</title>
          <description>To calculate the number of patients that exhibit PNS in all traditional vector</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="50"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Patients With PNS in All Vectors, That Could be Avoided With a Non-traditional Vector</title>
        <description>To calculate the number of patients, who exhibit PNS in all traditional vector, in which PNS could be avoided using a non-traditional vector</description>
        <time_frame>At 6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>No Arms</title>
            <description>All patient have a Quartet LV lead. No arms</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Patients With PNS in All Vectors, That Could be Avoided With a Non-traditional Vector</title>
          <description>To calculate the number of patients, who exhibit PNS in all traditional vector, in which PNS could be avoided using a non-traditional vector</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="50"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>6 months period</time_frame>
      <group_list>
        <group group_id="E1">
          <title>No Arms</title>
          <description>All patient have a Quartet LV lead. No arms</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="51"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Dyspnea, angina pectoris, severe LV dysfunction, stent implantation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="51"/>
              </event>
              <event>
                <sub_title>Atrial fibrillation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="51"/>
              </event>
              <event>
                <sub_title>Dyspnea due to renal failure, pulmonary edema, flutter</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="51"/>
              </event>
              <event>
                <sub_title>Congestive cardiac insufficiency</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="51"/>
              </event>
              <event>
                <sub_title>Renal insufficiency, cardiogenic shock and flutter</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="51"/>
              </event>
              <event>
                <sub_title>Fatigue, hypotension episode</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="51"/>
              </event>
              <event>
                <sub_title>Atrial fibrillation, cardiovertion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="51"/>
              </event>
              <event>
                <sub_title>Dyspnea, acute lung edema after ICD explant and CRT implant Hypoxemia, COPD worsening renal failure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="51"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Fever, infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="51"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Cognitive impairment, disorientation, injury from tumoral origin</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="51"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Renal function worsening</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="51"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Pneumothorax, lung was needled during implantation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="51"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>RV lead dislodgment</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="51"/>
              </event>
              <event>
                <sub_title>LV lead dislocation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="51"/>
              </event>
              <event>
                <sub_title>Pain at the pocket of device</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="51"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="51"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr Javier Alzueta</name_or_title>
      <organization>Hospital Universitario Virgen de la Victoria</organization>
      <phone>+34 952 64 15 50</phone>
      <email>jalzueta@telefonica.net</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

